Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Lannett Company, Inc.    LCI

LANNETT COMPANY, INC. (LCI)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Lannett : Appoints Samuel H. Israel As General Counsel

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/17/2017 | 12:54pm CET

PHILADELPHIA, July 17, 2017 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the appointment of Samuel H. Israel as vice president, chief legal officer and general counsel.

"I am very pleased to welcome Sam to the Lannett senior management team," said Arthur Bedrosian, chief executive officer of Lannett. "Sam is an exceptional attorney, with more than 20 years of strategic and legal experience representing life sciences and healthcare companies. For the last 19 years, he served as Lannett's outside general counsel, coordinating all aspects of the company's legal work and helping to guide its growth, which will allow him to hit the ground running. Sam strengthens our team, as well as our ability to expand our business both domestically and globally."

Prior to joining Lannett, Israel, 55, was a partner with Fox Rothschild, a national, full-service law firm, with 22 offices that provide services in more than 60 practice areas. He served as chair of the firm's Pharmaceutical and Biotechnology Practice and handled a variety of commercial litigation matters. Israel earned a bachelor of science degree in chemical engineering from the University of Pennsylvania and a juris doctor degree with honors from Rutgers University School of Law. He lives in Philadelphia with his wife and daughter.

About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company's website at www.lannett.com.

Contact: Robert Jaffe
Robert Jaffe Co., LLC
(424) 288-4098

View original content with multimedia:http://www.prnewswire.com/news-releases/lannett-appoints-samuel-h-israel-as-general-counsel-300488843.html

SOURCE Lannett Company, Inc.


© PRNewswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LANNETT COMPANY, INC.
12/13 LANNETT : To Participate At Two Investment Conferences In December
12/12 ROBBINS ARROYO LLP : Is Investigating the Officers and Directors of Lannett Comp..
12/11 LANNETT : To Participate At Two Investment Conferences In December
12/07 LANNETT : Announces Agreement For Authorized Generic Version Of Toprol-XL®
12/07 LANNETT : Announces FDA Acceptance Of 505b2 New Drug Application For Cocaine Hyd..
12/04 LANNETT : Announces FDA Acceptance Of 505(b)(2) New Drug Application For Cocaine..
12/01 LANNETT : Announces Agreement For Authorized Generic Version Of Toprol-XL
12/01 LANNETT : Announces FDA Acceptance Of 505(b)(2) New Drug Application For Cocaine..
11/29 LANNETT : Announces Agreement For Authorized Generic Version Of Toprol-XL®
11/28 SCOTT+SCOTT, ATTORNEYS AT LAW, LLP : is Investigating Derivative Claims on Behal..
More news
News from SeekingAlpha
12/08 YOUR DAILY PHARMA SCOOP : Geron Update, Acorda Resubmits NDA, Sage Rallies
12/06 YOUR DAILY PHARMA SCOOP : Acadia Valuation, Galectin Plunges, Revance Positive R..
12/01 FDA accepts Lannett's marketing application for topical cocaine anesthetic
12/01 FDA OKs Indivior's Sublocade for opioid dependence
11/28 YOUR DAILY PHARMA SCOOP : Synergy In 2018, Repatha Action Date, Alkermes Signs D..